Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Biol Pharm Bull ; 37(5): 826-33, 2014.
Article in English | MEDLINE | ID: mdl-24599032

ABSTRACT

In Alzheimer's disease (AD), extensive neuronal loss and a deficiency of the neurotransmitter acetylcholine (ACh) are the major characteristics during pathogenesis in the brain. In the present study, we aimed to investigate whether representative ginsenosides from ginseng can regulate choline acetyltransferase (ChAT) and vesicular acetylcholine transporter (VAChT), which are required for cholinergic neurotransmission. Our results revealed that Re and Rd induced effectively the expression of ChAT/VAChT genes in Neuro-2a cells as well as ACh elevation. Microtubule-associated protein-2 (MAP-2), nerve growth factor receptor (p75), p21, and TrkA genes and proteins were also significantly expressed. Moreover, both activated extracelullar signal-regulated protein kinase (ERK) and Akt were inhibited by K252a, a selective Trk receptor inhibitor. These findings strongly indicate that Re and Rd play an important role in neuronal differentiation and the nerve growth factor (NGF)-TrkA signaling pathway. High performance liquid chromatography analysis showed that Re and Rd administered orally were transported successfully into brain tissue and increased the level of ChAT and VAChT mRNA. The present study demonstrates that Re and Rd are selective candidates for upregulation of the expression of cholinergic markers, which may counter the symptoms and progress of AD.


Subject(s)
Acetylcholine/biosynthesis , Cell Differentiation/drug effects , Gene Expression Regulation/drug effects , Ginsenosides/pharmacology , Neurons/cytology , Neurons/drug effects , Animals , Biomarkers/metabolism , Cell Line , Choline O-Acetyltransferase/biosynthesis , Ginsenosides/pharmacokinetics , Mice , Microtubule-Associated Proteins/biosynthesis , Neurons/metabolism , Receptor, Nerve Growth Factor/biosynthesis , Receptor, trkA/biosynthesis , Vesicular Acetylcholine Transport Proteins/biosynthesis , rho GTP-Binding Proteins/biosynthesis
2.
J Pharm Pharmacol ; 66(3): 466-76, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24354475

ABSTRACT

OBJECTIVES: In the present study, we aimed to examine whether fractions from an edible sea weed, Hizikia fusiformis, had immunomodulatory effects, particularly an anti-atopic effect, by attenuating the expression of T cell-dependent cytokines using in-vitro and in-vivo animal atopic dermatitis-like models. METHODS: The anti-atopic activities were examined in in vitro, and a 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis-like mouse model using quantitative real-time polymerase chain reaction, electrophoretic-mobility shift and histopathological analysis. KEY FINDINGS: Our results showed that the final fraction (F2') of H. fusiformis contained a higher amount of butanoic acid which was not found in the other fractions, and effectively inhibited T cell activation by inhibiting dephosphorylation of nuclear factor of activated T cells in electrophoretic-mobility shift assay. As a consequence, helper T cell-dependent cytokines, such as interleukin-2, -4 and interferon-γ, were significantly inhibited while activated with an anti-CD3 antibody. We also showed that skin challenged with DNCB successfully recovered when treated with 2.5 mg/kg, comparable to that by 0.25% prednicarbate. These results indicate that F2' may contribute to inhibit T cell activation by eliminating Th cell-dependent cytokines. CONCLUSIONS: Taken together, we concluded that F2' containing butanoic acid may be a new functional anti-atopic candidate, which probably acts through nuclear factor of activated T cell inactivation mechanisms.


Subject(s)
Butyric Acid/pharmacology , Cytokines/metabolism , Dermatitis, Atopic/immunology , Immunologic Factors/pharmacology , Seaweed/chemistry , Skin/drug effects , T-Lymphocytes, Helper-Inducer/metabolism , Animals , Antibodies/blood , Butyric Acid/analysis , Butyric Acid/therapeutic use , CD3 Complex/metabolism , Dermatitis, Atopic/chemically induced , Dermatitis, Atopic/drug therapy , Dermatitis, Atopic/metabolism , Dinitrochlorobenzene , Disease Models, Animal , Immunologic Factors/therapeutic use , Lymphocyte Activation/drug effects , Male , Mice , Mice, Inbred BALB C , NFATC Transcription Factors/metabolism , Phosphorylation , Phytotherapy , Plant Extracts/pharmacology , Plant Extracts/therapeutic use
3.
J Agric Food Chem ; 60(21): 5438-45, 2012 May 30.
Article in English | MEDLINE | ID: mdl-22563735

ABSTRACT

This study examined whether steam-dried ginseng berries fermented with Lactobacillus plantarum (FSGB) could improve the indices of type 2 diabetes mellitus (T2DM) in obese db/db mice. FSGB was shown to have an effect on body weight and blood glucose/serum parameters when administered at a dose of 0.5 g/kg. In the intraperitoneal glucose tolerance test (IPGTT) and insulin tolerance test (ITT), FSGB was clearly shown to improve insulin tolerance and glucose tolerance. Moreover, FSGB was shown to enhance immune activities by increasing the immune cell population, and glucose transpoter 1 (GLUT1) mRNA expression in L6 cells was up-regulated, suggesting that FSGB can increase glucose transport activity in target cells. These results indicate that steam- and dry-processed ginseng berries fermented with L. plantarum can be used to effectively control blood sugar metabolism via improving insulin and glucose tolerance and body weight gain in db/db mice.


Subject(s)
Blood Glucose/analysis , Body Weight/drug effects , Diabetes Mellitus, Type 2/drug therapy , Hypoglycemic Agents/administration & dosage , Lactobacillus plantarum/metabolism , Panax/chemistry , Plant Extracts/administration & dosage , Animals , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/physiopathology , Fermentation , Fruit/chemistry , Fruit/microbiology , Humans , Hypoglycemic Agents/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Obese , Panax/microbiology , Phytotherapy , Plant Extracts/metabolism , Up-Regulation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...